Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more) Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Redwood Scientific Technologies Inc (EM) RSCI

Consumer Defensive Healthcare Household & Personal Products Drug Manufacturers - Specialty & Generic
Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.


EXPM:RSCI - Post by User

Redwood Scientific Technologies Inc (EM)
<< Previous
 Bullboard Posts
User Avatar Image
(18)
•••
  • lelianicruzX
Post by lelianicruzon Jul 09, 2024 11:42am
75 Views
Post# 36124490

Comprehensive Nicotine Addiction Solutions by RSCI

Comprehensive Nicotine Addiction Solutions by RSCIRedwood Scientific Technologies ($RSCI) targets both cigarette and vape nicotine addictions, aiming for comprehensive solutions. With a market cap of $131,164,033 and 495,000,000 authorized shares, RSCI is poised for sustained growth in the pharmaceutical sector, focusing on innovative products and clinical trials to combat nicotine addiction effectively.
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities